Trigran group reports 4.2% MiMedx (MDXG) stake in amended Schedule 13G
Filing Impact
Filing Sentiment
Form Type
SCHEDULE 13G/A
Rhea-AI Filing Summary
MiMedx Group, Inc. has a new ownership update from Trigran-affiliated investors. An amended Schedule 13G shows Trigran Investments, Inc. and related individuals collectively reporting beneficial ownership of 6,163,384 shares of MiMedx common stock, representing 4.2% of the outstanding class as of the reported date.
The group reports no sole voting or dispositive power, with shared voting power over 5,688,192 shares and shared dispositive power over 6,163,384 shares. The filers state the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of MiMedx.
Positive
- None.
Negative
- None.
FAQ
What ownership stake in MiMedx Group (MDXG) does Trigran report in this Schedule 13G/A?
Trigran Investments, Inc. and related individuals report beneficial ownership of 6,163,384 shares of MiMedx common stock, representing 4.2% of the outstanding class. This reflects their aggregated position as of the event date disclosed in the filing.
Who are the reporting persons in the MiMedx (MDXG) Schedule 13G/A amendment?
The filing lists Trigran Investments, Inc. plus individuals Douglas T. Granat, Lawrence A. Oberman, Steven G. Simon, Bradley F. Simon, and Steven R. Monieson as reporting persons. They also file an Agreement to Make a Joint Filing as an exhibit.
Do the Trigran reporting persons seek control of MiMedx Group (MDXG)?
The certification states the MiMedx securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer, other than activities solely in connection with a nomination under Rule 14a-11.
Why does the MiMedx (MDXG) Schedule 13G/A mention ownership of 5 percent or less?
Item 5 notes ownership of 5 percent or less of a class, consistent with the reported 4.2% beneficial ownership. This indicates the reporting group’s stake is below the 5% threshold that typically triggers initial Schedule 13D or 13G reporting.